PALB2-mutated human mammary cells display a broad spectrum of morphological and functional abnormalities induced by increased TGFβ signaling von Tuppurainen, Hanna, Laurila, Niina, Nätynki, Marjut, Eshraghi, Leila, Tervasmäki, Anna, Erichsen, Louisa, Sørensen, Claus Storgaard, Pylkäs, Katri, Winqvist, Robert, Peltoketo, Hellevi

Volltext

BRCA1 mislocalization leads to aberrant DNA damage response in heterozygous ABRAXAS1 mutation carrier cells von Bose, Muthiah, Sachsenweger, Juliane, Laurila, Niina, Parplys, Ann Christin, Willmann, Jonas, Jungwirth, Johannes, Groth, Marco, Rapakko, Katrin, Nieminen, Pentti, Friedl, Thomas W P, Heiserich, Lisa, Meyer, Felix, Tuppurainen, Hanna, Peltoketo, Hellevi, Nevanlinna, Heli, Pylkäs, Katri, Borgmann, Kerstin, Wiesmüller, Lisa, Winqvist, Robert, Pospiech, Helmut

Volltext

Cationic tantalum oxide nanoparticle contrast agent for micro computed tomography reveals articular cartilage proteoglycan distribution and collagen architecture alterations von Jäntti, Jiri, Joenathan, Anisha, Fugazzola, Maria, Tuppurainen, Juuso, Honkanen, Juuso T J, Töyräs, Juha, van Weeren, René, Snyder, Brian D, Grinstaff, Mark W, Matikka, Hanna, Mäkelä, Janne T A

Volltext

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice von Kujala, Anni, Valkonen, Elina, Sallinen, Hanna, Tuppurainen, Laura, Laakso, Hanne, Ylä-Herttuala, Elias, Liimatainen, Timo, Kujala, Jouni, Jokelainen, Otto, Sironen, Reijo, Anttila, Maarit, Ylä-Herttuala, Seppo

Volltext

Abstract 5205: CCND1 is a miR-193b target in prostate cancer von Tuppurainen, Kirsi M., Rauhala, Hanna E., Scaravilli, Mauro, Vessella, Robert L., Visakorpi, Tapio

Volltext

Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice von Tuppurainen, Laura, Sallinen, Hanna, Karvonen, Anni, Valkonen, Elina, Laakso, Hanne, Liimatainen, Timo, Hytönen, Elisa, Hämäläinen, Kirsi, Kosma, Veli-Matti, Anttila, Maarit, Ylä-Herttuala, Seppo

Volltext

Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma von Sopo, Minna, Anttila, Maarit, Sallinen, Hanna, Tuppurainen, Laura, Laurema, Anniina, Laidinen, Svetlana, Hamalainen, Kirsi, Tuunanen, Pasi, Koponen, Jonna K., Kosma, Veli-Matti, Heinonen, Seppo, Alitalo, Kari, Yla-Herttuala, Seppo

Volltext

Abstract 5217: Integrative sequencing reveals novel alterations in untreated and castration resistant prostate cancer von Annala, Matti J., Waltering, Kati K., Ylipää, Antti, Kartasalo, Kimmo, Tuppurainen, Kirsi, Karakurt, Serdar, Latonen, Leena, Saramäki, Outi, Leppänen, Simo-Pekka, Seppälä, Janne, Rauhala, Hanna E., Tammela, Teuvo LJ, Yli-Harja, Olli, Zhang, Wei, Visakorpi, Tapio, Nykter, Matti

Volltext

Preclinical safety, toxicology, and biodistribution study of adenoviral gene therapy with sVEGFR-2 and sVEGFR-3 combined with chemotherapy for ovarian cancer von Tuppurainen, Laura, Sallinen, Hanna, Kokki, Emmi, Koponen, Jonna, Anttila, Maarit, Pulkkinen, Kati, Heikura, Tommi, Toivanen, Pyry, Hämäläinen, Kirsi, Kosma, Veli-Matti, Heinonen, Seppo, Alitalo, Kari, Ylä-Herttuala, Seppo

Volltext